Press release
Kepley BioSystems in Top Tier at Hello Tomorrow Global Summit
Dr. Anthony L. Dellinger waits to discuss Kepley BioSystems synthetic crustacean bait, OrganoBait? with members of Bloomberg News.
Kepley BioSystems is pleased to announce that their National Science Foundation-funded synthetic crustacean bait helped place KBI in the top 1% of global start-ups in the Hello Tomorrow continuum. Start-up company competitors came from over 105 countries from around the world.
Over the two-day conference, KBI was able to present the dramatic equity potential for early capital in Kepley to elite investors and conference attendees. Among them were executives from sponsors that included Roche, Air Liquide, AIRBUS, L’Oreal, Carrefour and Michelin, along with Bloomberg News, The Boston Consulting Group and other global media and industry partners.
“The event was instructive and inspiring, including a keynote address by Michael Bloomberg, and as judged, we were among the top tier participants of science and technology entrepreneurs’ reinforcing our product mission,” said Dr. Anthony Dellinger, President of Kepley BioSystems.
# # #
About Kepley BioSystems
Kepley BioSystems originated at the Joint School of Nanoscience and Nanoengineering (JSNN), North Carolina A&T State University and The University of North Carolina at Greensboro; the company is now located at the Gateway University Research Park proximal to JSNN. Kepley BioSystems is an academically-driven company led by Professor Christopher Kepley and Dr. Anthony Dellinger, a recent graduate, working in collaboration with lead inventor Terry E. Brady, located on the Caribbean island of Anguilla, British West Indies. For more information, visit: http://www.kepleybiosystems.com
About Hello Tomorrow
Hello Tomorrow is a non-profit organization founded in 2011. It aims to bridge the gap between science entrepreneurs, investors, and corporations in all major scientific and technological fields. Today, it is a global, interdisciplinary community with presence across 45 countries, gathering more than 15,000 innovators within the Hello Tomorrow ecosystem. The Hello Tomorrow Challenge, a global start-up competition, has attracted nearly 5,000 start-ups across 112 countries since its inception in 2014. To date, €65 million has been raised by Hello Tomorrow’s finalists.
Anthony L. Dellinger, Ph.D. – President, Adjunct Researcher
Kepley BioSystems Incorporated
Joint School of Nanoscience & Nanoengineering
Phone: 336-217-5163
Email: adellinger@kepleybiosystems.com
Facebook: https://www.facebook.com/kepleybiosystems/
Twitter: https://twitter.com/organobait
Linkedin: https://www.linkedin.com/in/anthonydellinger
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kepley BioSystems in Top Tier at Hello Tomorrow Global Summit here
News-ID: 373846 • Views: …
More Releases from Kepley BioSystems, Inc.
KePSLA joins hands with IDS Next
KePSLA and IDS NEXT have announced a partnering agreement, where KePSLA’s proprietary Business Intelligence Solutions will now be available to all IDS Next Customers. IDS will be able to provide their actionable insights on guest experience, influence marketing, online presence & reputation management to their large and marquee set of hoteliers through a single seamless experience.
All customer of IDS will now work out of a single sign-on process, both…
Kepley BioSystems Incorporated selected as finalist in 2016 NC IDEA challenge
Greensboro, NC, November 1, 2016 -- Kepley BioSystems announced today that their team has been selected as a Top 25 finalist in the 2016 NC IDEA grant program. NC IDEA provides semi-annual grant solicitations for ideas with the potential to become high-growth companies. The grant program is a catalyst for technological breakthroughs developed in North Carolina that have a significant potential to successfully transition commercially viable high-growth enterprise. Their mission…
Kepley BioSystems Selected as a Hello Tomorrow Challenge Finalist
Competing with 70 other extraordinary startup companies from around the world, Kepley BioSystems was named as a top finalist in the Hello Tomorrow Challenge. Originally, 3,500 companies from 105 countries had entered the competition, and recently the field was narrowed to 500 semi-finalists. Now, just 70 companies that have been invited to make presentations at the Hello Tomorrow Global Summit on October 13 and 14 in Paris, France, where they…
More Releases for BioSystems
Microelectrode Arrays (MEAs) Market Size And Forecast | MaxWell Biosystems, Axio …
New Jersey, United States - The research study offers an in-depth assessment of the Microelectrode Arrays (MEAs) Market and helps market players to gain a foothold in the industry. It highlights critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for the challenges ahead. It provides a regional analysis of the Microelectrode Arrays (MEAs) market to uncover major opportunities available in different parts of the…
Multiplex Biomarker Imaging Market 2027 | ToposNomos Ltd, Perkin Elmer, Inc., Le …
A study on the global multiplex biomarker imaging market has been conducted by Research Report Insights during the assessment period (2017-2027). The study reveals the value forecast of the market and highlights factors influencing the growth of the market. In terms of revenues, the market will expand from approximately US$ 271 Mn in 2017 to over US$ 840 Mn by the end of 2027, riding on healthy double-digit CAGR during…
Multiplex Biomarker Imaging Market 2027 | Leica Biosystems Nussloch GmbH, Thermo …
A study on the global multiplex biomarker imaging market has been conducted by Research Report Insights during the assessment period (2017-2027). The study reveals the value forecast of the market and highlights factors influencing the growth of the market. In terms of revenues, the market will expand from approximately US$ 271 Mn in 2017 to over US$ 840 Mn by the end of 2027, riding on healthy double-digit CAGR during…
Mannanase Market 2017 - American Biosystems, Elanco
Apex Research, recently published a detailed market research study focused on the "Mannanase Market" across the global, regional and country level. The report provides 360° analysis of "Mannanase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Mannanase industry, and estimates the future trend of Mannanase market on the basis of…
Global Biomedical Nanoscale Devices Market 2017 : Triton BioSystems, Zeptosens A …
Biomedical Nanoscale Devices
A market study based on the " Biomedical Nanoscale Devices Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Biomedical Nanoscale Devices Market 2017’. The research report analyses the historical as well as present performance of the worldwide Biomedical Nanoscale Devices industry, and makes predictions on the future status of Biomedical Nanoscale Devices market on the basis of this analysis.
Get Free…
Global Laboratory distillation systems Market 2017 : Shanghai Sanch Medical Inst …
Laboratory distillation systems
A market study based on the " Laboratory distillation systems Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Laboratory distillation systems Market 2017’. The research report analyses the historical as well as present performance of the worldwide Laboratory distillation systems industry, and makes predictions on the future status of Laboratory distillation systems market on the basis of this analysis.
Get Free…
